NCT00375999View on ClinicalTrials.gov

Docetaxel and Epirubicin in Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Stomach Neoplasms
Interventions
DRUG

Docetaxel and epirubicin

Trial Locations (1)

Unknown

Yongdong Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT00375999 - Docetaxel and Epirubicin in Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter